{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:25:44Z","timestamp":1770218744828,"version":"3.49.0"},"reference-count":71,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":8196,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1984,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinical and experimental observations have firmly established the concept of a two\u2010way interaction between malignancy and the hemostatic system. On the one hand, certain tumors can activate platelets and the coagulation mechanism in vivo, on the other, a convincing case has been made for the involvement of platelets and fibrin in tumor growth and metastasis. A large number of clinical and experimental studies have been conducted in order to test the efficacy of platelet inhibitors and anticoagulants as adjuvants in the treatment of cancer. Antiplatelet drugs gave variable results, depending on the drug and the tumor system tested. Prostaglandin synthetic pathways by both the host and tumor seem to be an important determinant in the response to platelet function inhibitors. Of the various anticoagulants tested, the coumarin derivatives gave somewhat consistent antitumor effect in certain human and experimental cancer. The antitumor effect of oral anticoagulants does not appear to be a primary drug effect and seems related to their role as vitamin K antagonists. It should be emphasized that although the antitumor potential of antithrombotic agents is a subject of keen interest at the present, their use in treating human cancer is still controversial.<\/jats:p>","DOI":"10.1002\/ajh.2830160213","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T09:38:32Z","timestamp":1172050712000},"page":"193-202","source":"Crossref","is-referenced-by-count":24,"title":["Tumor interaction with hemostasis: The rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer"],"prefix":"10.1002","volume":"16","author":[{"given":"Hamid","family":"Al\u2010Mondhiry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"355","volume-title":"Lectures on Surgical Pathology and Therapeutics, A Handbook for Students and Practitioners","author":"Billroth T","year":"1878"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1700200109"},{"key":"e_1_2_1_4_2","first-page":"245","article-title":"The fate of carcinoma emboli in the lung","volume":"23","author":"Saphir O","year":"1947","journal-title":"Am J Pathol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(68)90044-2"},{"key":"e_1_2_1_6_2","first-page":"137","article-title":"Fibrin formation and tumour growth","volume":"28","author":"O'Meara RAQ","year":"1968","journal-title":"Thrombos Diath Hemorrh [Suppl]"},{"key":"e_1_2_1_7_2","first-page":"301","article-title":"The adhesion of thromboplastic tumor emboli to vessel walls in vivo","volume":"53","author":"Warren BA","year":"1972","journal-title":"Br J Exp Pathol"},{"key":"e_1_2_1_8_2","first-page":"570","article-title":"The ultrastructure of platelet pseudopodia and the adhesion of homologous platelets to tumour cells","volume":"51","author":"Warren BA","year":"1970","journal-title":"Br J Exp Pathol"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:5<751::AID-CNCR2820200529>3.0.CO;2-E"},{"key":"e_1_2_1_10_2","first-page":"837","article-title":"Studies with 133I\u2010labelled antibody to human fibrinogen for diagnosis and therapy of tumors","volume":"7","author":"McCardle RJ","year":"1966","journal-title":"J Nucl Med"},{"key":"e_1_2_1_11_2","first-page":"493","article-title":"Sequence of events in experimental metastasis of Walker 256 tumors: Light, immunofluorescent and electron microscopic observations","volume":"46","author":"Jones JD","year":"1971","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:5<865::AID-CNCR2820200546>3.0.CO;2-5"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1974.tb00508.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197211162872001"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197502)35:2<432::AID-CNCR2820350219>3.0.CO;2-6"},{"issue":"6","key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1182\/blood.V59.6.1252.1252","article-title":"Interruption of tumor\u2010associated platelet consumption with platelet enzyme inhibitors","volume":"59","author":"Slichter SJ","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1973.168"},{"key":"e_1_2_1_18_2","unstructured":"Owen CA Jr Bowie EJW (eds): Symposium on the intravascular coagulation\u2010fibrinolysis (ICF) syndromes.Mayo Clin Proc49:627\u2013698 1974."},{"key":"e_1_2_1_19_2","first-page":"433","article-title":"Hematologic changes and thromboembolic complications in neoplastic diseases and their relationship to metastasis","volume":"6","author":"Ambrus JL","year":"1975","journal-title":"J Med"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1651366"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197756010-00001"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.48.7.1172"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.61.1.46"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910110322"},{"key":"e_1_2_1_25_2","first-page":"429","volume-title":"Interaction of Platelets and Tumor Cells","author":"Gasic GJ","year":"1982"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.7.4336"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-95-5-636"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.4.1765"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/282076a0"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7015512"},{"key":"e_1_2_1_31_2","first-page":"295","volume-title":"Interaction of Platelet and Tumor Cells","author":"Honn KV","year":"1982"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.68.2.271"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(74)90484-4"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.71.4.1207"},{"key":"e_1_2_1_35_2","first-page":"233","volume-title":"Interaction of Platelets and Tumor Cells","author":"Lipton A","year":"1982"},{"key":"e_1_2_1_36_2","first-page":"249","volume-title":"Interaction of Platelets and Tumor Cells","author":"Cowan DH","year":"1982"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830140202"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.V57.2.199.199","article-title":"Plasma levels of beta\u2010thromboglobulin and platelet factor 4 as indices of platelet activation in vivo","volume":"57","author":"Kaplan KL","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1159\/000207575"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(72)92581-0"},{"key":"e_1_2_1_41_2","first-page":"932","article-title":"Haematological effects of aspirin","volume":"2","author":"Kolenich JJ","year":"1977","journal-title":"Lancet"},{"key":"e_1_2_1_42_2","first-page":"207","article-title":"Arvin\u2010induced hypofibrinogenemia and metastasis formation from bloodborne cancer cells","volume":"133","author":"Wood S","year":"1973","journal-title":"Johns Hopkins Med J"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00286943"},{"key":"e_1_2_1_44_2","first-page":"435","article-title":"Studies on platelet aggregation inhibitors in vivo. VIII. Effect of pentoxifylline on spontaneous tumor metastasis","volume":"10","author":"Gordon S","year":"1979","journal-title":"J Med"},{"key":"e_1_2_1_45_2","unstructured":"Al\u2010MondhiryH DragoJ:Effect of Bay g 6575 on metastatic prostatic tumor in rats. (In preparation.)"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)90154-3"},{"key":"e_1_2_1_47_2","first-page":"511","volume-title":"Advances in Prostoglandin and Thromboxane Research","author":"Powles TJ","year":"1980"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02950524"},{"key":"e_1_2_1_49_2","first-page":"255","article-title":"The activation of coagulation by extracts of mucus: A possible pathway of intravascular coagulation accompanying adenocarcinomas","volume":"82","author":"Pineo GF","year":"1973","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1974.tb14458.x"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(75)90018-3"},{"key":"e_1_2_1_52_2","first-page":"65","volume-title":"Malignancy and the Hemostatic System","author":"Semeraro N","year":"1981"},{"key":"e_1_2_1_53_2","first-page":"57","volume-title":"Malignancy and the Hemostatic System","author":"Galnick HR","year":"1981"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90079-2"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(66)90393-7"},{"key":"e_1_2_1_56_2","first-page":"61","volume-title":"Onkohamstaseologic","author":"Laki K","year":"1975"},{"key":"e_1_2_1_57_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/030089167005600102","article-title":"Enhancement of pulmonary metastasis following intravenous injection of a suspension of ellagic acid","volume":"56","author":"Agostine D","year":"1970","journal-title":"Tumori"},{"key":"e_1_2_1_58_2","first-page":"1064","article-title":"Tumor metastasis and anticoagulants","volume":"132","author":"Olwin JH","year":"1971","journal-title":"Surg Gynecol Obstet"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108743"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197908)44:2<732::AID-CNCR2820440246>3.0.CO;2-Y"},{"key":"e_1_2_1_61_2","first-page":"103","volume-title":"Malignancy and the Hemostatic System","author":"Hilgard P","year":"1981"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197501)35:1<91::AID-CNCR2820350114>3.0.CO;2-Z"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5819.174-d"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197806)41:6<2475::AID-CNCR2820410657>3.0.CO;2-3"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310330021017"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.2930050212"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197507)36:1<129::AID-CNCR2820360109>3.0.CO;2-S"},{"key":"e_1_2_1_68_2","first-page":"575","article-title":"Trial of heparin and cyclophosphomide (NSC\u201026271) in the treatment of lung cancer","volume":"60","author":"Edlis HE","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_69_2","first-page":"1399","article-title":"Heparin and polychemotherapy for treatment of lung cancer","volume":"61","author":"Rohwedder JJ","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_70_2","first-page":"69","article-title":"Effects of sodium warfarin and other carcinostatic agents on malignant cells: A study of drug synergy","volume":"5","author":"Kirsch WM","year":"1974","journal-title":"J Med"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1159\/000224819"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(79)90058-6"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830160213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830160213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T07:55:49Z","timestamp":1697788549000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830160213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,2]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1984,2]]}},"alternative-id":["10.1002\/ajh.2830160213"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830160213","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,2]]}}}